The office of Mallinckrodt’s regional Asia/Pacific headquarters in Singapore has been awarded “business headquarters” status by the Singapore Economic Development Board.Mallinckrodt’s business tax rate will be reduced to 13% from
The office of Mallinckrodts regional Asia/Pacific headquarters in Singapore has been awarded business headquarters status by the Singapore Economic Development Board.
Mallinckrodts business tax rate will be reduced to 13% from 25% for the five years of the status, said Robert Martsching, Mallinckrodt investor spokesman. The business development designation was awarded in recognition of the pharmaceutical and medical imaging companys commitment to regional business growth.
Singapore business development officials say they hope to establish Mallinckrodt as one of the most dynamic and fastest growing healthcare companies in the Asia/Pacific region. Mallinckrodts regional headquarters in Singapore has 34 employees and is headed by Kin Chua, president of Mallinckrodt Asia/Pacific.
Staff members provide marketing, technical, financial, and administrative support to Mallinckrodt offices and employees throughout the Pacific Rim, including Australia, China, Hong Kong, India, Korea, Japan, and Taiwan. Mallinckrodts Singapore office has established a clinical education center to enhance the technical skills of providers, distributors, and employees.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.